Biblio Discovery — Demo Discovery Service

24 hasil untuk "Pascal Girard"

Menampilkan 1–20 · 1,06 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Ultra-rapid categorization of fourier-spectrum equalized natural images: macaques and humans perform similarly.

    Pascal Girard; Roger Koenig-Robert

    PLoS ONE, Vol. 6 No. 2 · 2011 · Inggris · DOAJ Scopus

    BACKGROUND: Comparative studies of cognitive processes find similarities between humans and apes but also monkeys. Even high-level processes, like the ability to categorize classes of object from any natural scene under ultra-rapid time constraints, seem to be present in rhesus macaque monkeys…

    Juga tersedia di: PLOS

  2. Artikel Jurnal

    Location and temporal memory of objects declines in aged marmosets (Callithrix jacchus)

    Vanessa De Castro; Pascal Girard

    Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Episodic memory decline is an early marker of cognitive aging in human. Although controversial in animals and called “episodic-like memory”, several models have been successfully developed, however they rarely focused on ageing. While marmoset is an emerging primate model in aging science…

  3. Artikel Jurnal

    “What”, “Where”, and “Contextual" memory decline with ageing in marmosets, insights from a computerized task

    Amirouche Sadoun; Pascal Girard; Vanessa De Castro

    Revue de Primatologie, Vol. 16 · 2025 · Prancis · DOAJ

    Episodic memory impairments are a key feature of age-related cognitive decline. This study introduced a touch-screen task to assess the "what-where-which" components of episodic-like memory in marmosets (Callithrix jacchus). The task used naturalistic contexts featuring conspecific faces at…

  4. Artikel Jurnal

    Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants

    Orestis Papasouliotis; David Mitchell; Pascal Girard dkk.

    Clinical and Translational Science, Vol. 15 No. 12 · 2022 · Inggris · DOAJ Scopus

    Abstract Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown therapeutic potential in relapsing multiple sclerosis. This analysis aimed to develop pharmacokinetic (PK) and pharmacodynamic (PD; BTK occupancy [BTKO]) models of evobrutinib and simulate PK and BTKO profiles under…

  5. Artikel Jurnal

    Determination of a clinically effective evobrutinib dose: Exposure–response analyses of a phase II relapsing multiple sclerosis study

    Orestis Papasouliotis; David Mitchell; Pascal Girard dkk.

    Clinical and Translational Science, Vol. 15 No. 12 · 2022 · Inggris · DOAJ Scopus

    Abstract The pharmacometric analysis of the double‐blind, randomized, phase II study (NCT02975349) investigating the safety and efficacy of evobrutinib, explored exposure–response relationships and suitable dosing regimens of evobrutinib for relapsing multiple sclerosis. Population pharmacokinetic…

  6. Artikel Jurnal

    Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

    Nadia Terranova; Pascal Girard; Konstantinos Ioannou dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 7 No. 4 · 2018 · Inggris · DOAJ Scopus

    Mathematical models of tumor dynamics generally omit information on individual target lesions (iTLs), and consider the most important variable to be the sum of tumor sizes (TS). However, differences in lesion dynamics might be predictive of tumor progression. To exploit this information, we have…

  7. Artikel Jurnal

    Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials

    Maria Pitsiu; Özkan Yalkinoglu; Colm Farrell dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 12 No. 8 · 2023 · Inggris · DOAJ Scopus

    Abstract B cell stimulating factor (BLyS) and a proliferation‐inducing ligand (APRIL) are targets for novel treatments in patients with systemic lupus erythematosus (SLE). Atacicept is a recombinant, soluble fusion protein that blocks BLyS and APRIL activity. This study characterized the…

  8. Artikel Jurnal

    Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study

    Ana‐Marija Grisic; Akash Khandelwal; Mauro Bertolino dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 9 No. 11 · 2020 · Inggris · DOAJ Scopus

    This study aimed to explore the currently competing and new semimechanistic clearance models for monoclonal antibodies and the impact of clearance model misspecification on exposure metrics under different study designs exemplified for cetuximab. Six clearance models were investigated under four…

  9. Artikel Jurnal Teks lengkap

    The variability of multisensory processes of natural stimuli in human and non-human primates in a detection task

    Cécile Juan; Céline Cappe; Baptiste Alric dkk.

    PLOS ONE, Vol. 12 No. 2 · 2017 · Inggris · PLOS Scopus

    Background: Behavioral studies in both human and animals generally converge to the dogma that multisensory integration improves reaction times (RTs) in comparison to unimodal stimulation. These multisensory effects depend on diverse conditions among which the most studied were the spatial and…

    Juga tersedia di: DOAJ

  10. Artikel Jurnal Teks lengkap

    The Sea Slug Doriopsilla areolata Bergh, 1880 (Mollusca, Gastropoda) in the Mediterranean Sea: Another Case of Cryptic Diversity

    Giulia Furfaro; Christopher Schreier; Egidio Trainito dkk.

    Diversity, Vol. 14 No. 4 · 2022 · Inggris · DOAJ Scopus

    The Mediterranean Sea diversity is still far from being fully disclosed. Marine Heterobranchia are one of the most paradigmatic species-rich groups, with many recent systematic studies revealing the high density of new, cryptic, and endemic species occurring in the Mediterranean basin. In this…

  11. Artikel Jurnal

    Predicting disease activity in patients with multiple sclerosis: An explainable machine‐learning approach in the Mavenclad trials

    Sreetama Basu; Alain Munafo; Ali‐Frederic Ben‐Amor dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 11 No. 7 · 2022 · Inggris · DOAJ Scopus

    Abstract Multiple sclerosis (MS) is among the most common autoimmune disabling neurological conditions of young adults and affects more than 2.3 million people worldwide. Predicting future disease activity in patients with MS based on their pathophysiology and current treatment is pivotal to…

  12. Artikel Jurnal

    Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models

    Kristyn Pantoja; Shankar Lanke; Alain Munafo dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 11 No. 10 · 2022 · Inggris · DOAJ Scopus

    Abstract One of the objectives of oncology phase I dose‐escalation studies has been to determine the maximum tolerated dose (MTD). Although MTD is no longer set as the dose for further development in contemporary oncology drug development, MTD determination is still important for informing the…

  13. Artikel Jurnal Teks lengkap

    Knowledge and Theme Discovery across Very Large Biological Data Sets Using Distributed Queries: A Prototype Combining Unstructured and Structured Data

    Uma S. Mudunuri; Mohamad Khouja; Stephen Repetski dkk.

    PLoS ONE, Vol. 8 No. 12 · 2013 · Inggris · PLOS Scopus

    As the discipline of biomedical science continues to apply new technologies capable of producing unprecedented volumes of noisy and complex biological data, it has become evident that available methods for deriving meaningful information from such data are simply not keeping pace. In order to…

    Juga tersedia di: DOAJ

  14. Artikel Jurnal

    Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non‐small cell lung cancer based on bintrafusp alfa trials

    Ana‐Marija Milenković‐Grišić; Nadia Terranova; Diane R. Mould dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 13 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract This analysis aimed to quantify tumor dynamics in patients receiving either bintrafusp alfa (BA) or pembrolizumab, by population pharmacokinetic (PK)‐pharmacodynamic modeling, and investigate clinical and molecular covariates describing the variability in tumor dynamics by pharmacometric…

  15. Artikel Jurnal

    Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose

    Wenyuan Xiong; Manja Friese‐Hamim; Andreas Johne dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 10 No. 5 · 2021 · Inggris · DOAJ Scopus

    Abstract Tepotinib is a highly selective and potent MET inhibitor in development for the treatment of patients with solid tumors. Given the favorable tolerability and safety profiles up to the maximum tested dose in the first‐in‐human (FIH) trial, an efficacy‐driven translational modeling approach…

  16. Artikel Jurnal

    Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab

    Nadia Terranova; Jonathan French; Haiqing Dai dkk.

    CPT: Pharmacometrics & Systems Pharmacology, Vol. 11 No. 3 · 2022 · Inggris · DOAJ Scopus

    Abstract Avelumab (anti–PD‐L1) is an approved anticancer treatment for several indications. The JAVELIN Gastric 100 phase III trial did not meet its primary objective of demonstrating superior overall survival (OS) with avelumab maintenance versus continued chemotherapy in patients with advanced…